Article Details

Acorda Therapeutics Inc (ACOR) Receives $21.71 Consensus PT from Analysts

Retrieved on: 2019-05-13 20:09:22

Tags for this article:

Click the tags to see associated articles and topics

Acorda Therapeutics Inc (ACOR) Receives $21.71 Consensus PT from Analysts. View article details on hiswai:

Excerpt

<div><b>Two Sigma Investments</b> LP bought a new position in shares of Acorda Therapeutics in the fourth quarter valued at $2,509,000. Finally, Oppenheimer ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo